RYRAX
Price
$52.14
Change
+$0.55 (+1.07%)
Updated
Jul 2 closing price
Net Assets
4.62M
VCDAX
Price
$204.82
Change
-$1.37 (-0.66%)
Updated
Jul 2 closing price
Net Assets
6.92B
Interact to see
Advertisement

RYRAX vs VCDAX

RYRAX vs VCDAX Comparison Chart in %
View a ticker or compare two or three
VS
RYRAX vs. VCDAX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYRAX is a Buy and VCDAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCDAX has more cash in the bank: 6.92B vs. RYRAX (4.63M). RYRAX pays higher dividends than VCDAX: RYRAX (1.93) vs VCDAX (0.72). RYRAX was incepted earlier than VCDAX: RYRAX (28 years) vs VCDAX (21 years). RYRAX (1.69) is less costly to investors than VCDAX (0.09). RYRAX is a more actively managed with annual turnover of: 296.00 vs. VCDAX (6.00). RYRAX has a lower initial minimum investment than VCDAX: RYRAX (2500) vs VCDAX (100000). VCDAX annual gain was more profitable for investors over the last year : 7.73 vs. RYRAX (3.79). VCDAX return over 5 years is better than : 24.87 vs. RYRAX (-3.62).
RYRAXVCDAXRYRAX / VCDAX
Total Expense Ratio1.640.091,822%
Annual Report Gross Expense Ratio1.690.091,878%
Fund Existence28 years21 years-
Gain YTD-0.5340.491-109%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRA1000N/A-
Net Assets4.63M6.92B0%
Annual Yield % from dividends1.930.72267%
Returns for 1 year3.797.7349%
Returns for 3 years34.5238.5190%
Returns for 5 years-3.6224.87-15%
Returns for 10 years122.38226.5854%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOPAX22.700.28
+1.25%
Fidelity Advisor Intl Sm Cap Opps A
BASVX16.050.03
+0.19%
Brown Advisory Sustainable Val Inst
ERBCX19.450.01
+0.05%
Eaton Vance Equity Strategy C
CPTUX93.64-1.71
-1.79%
Invesco Discovery Large Cap R5
EEMFX12.08-0.29
-2.34%
MFS Emerging Markets Equity Research R3